Under construction – not a live service
Sign in
Taking people in IranNo phase

Oregano and Basil Leaves in People With Unstable Angina

Tests extra oregano and basil leaves in people recently treated for unstable angina.

Plain-language title generated from the registry record
Registry title: Oregano and Basil Leaves and Coronary Artery Disease

Key facts

Where
Tehran, IranSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 75 years old?

Source: NCT07123181, who can take part

Where in Iran

  • Imam Husain hospitalTehran, IranTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Shahid Beheshti University of Medical Sciences
Trial code
NCT07123181
Record updated
16 June 2026
Original description
The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.Read full original descriptionShow less

Effects of Increasing Polyphenol Intake by Consumption of Oregano and Basil Leaves on Plasma Inflammatory and Lipid Factors and Total Urinary Polyphenol in Patients With Unstable Angina

The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.

Inclusion: Patients diagnosed with unstable angina.

Exclusion: Liver cirrhosis and advanced chronic kidney disease (CKD 5); Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications; Patients diagnosed with STEMI; Patients undergoing coronary artery bypass grafting; Pregnancy or breastfeeding.

ClinicalTrials.gov NCT07123181